TSRI scientists zero in on treatment for Charcot-Marie-Tooth disease LA JOLLA, CA March 8, 2018 About 1 in 2,500 people have a degenerative nerve disease called Charcot-Marie-Tooth (CMT). The disease is typically diagnosed in children, who can lose their ability to walk and use their hands for fine motor skills. There is no cure yet.
Scientists at The Scripps Research Institute (TSRI) have now shown a path to developing treatments for disease subtype CMT2D. As they report in the journal Nature Communications, it may be possible to reverse the disease by using a small molecule to restore normal protein function in the nervous system.
This study provides guidance for developing therapeutics, says Xiang-Lei Yang, PhD, TSRI professor and senior author of the study.
Importantly, the study reveals how a better understanding of the fundamental causes of CMT can point researchers toward a cure for other subtypes.
Detective work reveals new role for mutant protein
Here's a puzzle: CMT2D is caused by mutations in a protein called GlyRS, which is expressed by cells throughout the body. Yet, the disease only damages the peripheral nervous system the nerves in hands and feet.
Adding to the mystery, studies show that GlyRS primarily affects a process called protein synthesis, where genetic information is translated into proteins. Again, this process happens in all cells, so why would hands and feet be most affected?
Our everyday research is like a detective role, says Zhongying Mo, PhD, senior research associate at TSRI and first author of the study.
The new study offers the answer: GlyRS has a role outside protein synthesis.
The researchers discovered that mutations in GlyRS trigger unusual interactions between GlyRS and a protein called HDAC6. Normally, HDAC6 would regulate a process called acetylation, which readies a protein called -tubulin for its role in forming microtubules. Yang compares microtubules to a highway. Thanks to -tubulin, signaling proteins and other important molecules can zip along, sending signals from your tiptoes to your brain.
But in CMT, the aberrant protein interactions with HDAC6 prevent proper -tubulin acetylation, turning that highway into a dirt road. Nervous system signals can't run smoothly, and the longer the nerve, the rougher the road. Because our longest nerves reach our feet and hands, this finding explains why CMT2D is most severe in the peripheral nervous system even though the mutant proteins are everywhere in the body.
Further experiments in a mouse model of CMT2D showed that researchers could bring back proper nerve function by injecting the mice with a small molecule that blocks HDAC6 from interfering in -tubulin acetylation. Although this particular small molecule would not be safe for humans to take, Yang and Mo believe a similar molecule may work as a future CMT2D therapy.
It's exciting when you can accumulate all the evidence and point to a specific target, says Mo.
Targeting the root cause of CMT
Yang and Mo are excited to find this potential treatment target, but their ultimate goal is to treat the root cause of all types of CMT. To do this, they need to do more studies like this one, which reveal the fundamental pathology of the disease.
From patient to patient, different mutations can cause either mild or very severe symptoms. Some types of CMT are diagnosed in infancy, while others don't appear until adolescence. That variability is striking, Yang says.
Now that the researchers know about this GlyRS interaction with HDAC6, they would like to investigate where else mutant proteins in CMT are causing problems. In fact, an earlier study from the Yang lab caught another problem made by the mutant proteins, which has something to do with affecting nerve maintenance signal. Yang hopes future studies can solve these mysteries and even show a way to target mutant GlyRS itself.
Our understanding of the disease is ever-increasing, says Yang.
Additional authors of the study, Aberrant GlyRS-HDAC6 interaction links to axonal transport deficit in Charcot-Marie-Tooth neuropathy, were Huaqing Liu, Qinghua Hu, Jessica Pham, Na Wei, Ze Liu and Jiadong Zhou of The Scripps Research Institute; Xiaobei Zhao and Xu-Qiao Chen of the University of California, San Diego; Robert W. Burgess of The Jackson Laboratory; Samuel L. Pfaff of the Howard Hughes Medical Institute and the Salk Institute for Biological Studies; C. Thomas Caskey of Baylor College of Medicine; Ge Bai of The Scripps Research Institute and the Salk Institute of Biological Studies; and Chengbiao Wu of the University of California, San Diego, and the Veterans Affairs San Diego Healthcare System.
The study was supported the National Institutes of Health (grants R01 GM088278 and R01 NS054154) the Tau Consortium, The Larry L. Hillblom Foundation and by aTyr Pharma through an agreement with The Scripps Research Institute.
About The Scripps Research Institute
The Scripps Research Institute (TSRI) is one of the worlds largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists including two Nobel laureates and 20 members of the National Academies of Science, Engineering or Medicine work toward their next discoveries. The institutes graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. In October 2016, TSRI
Most recent headlines
09/11/2025
Dalet today announced a transformative leap forward for media operations: Agentic Artificial Intelligence (AI) that unifies the Dalet ecosystem under one natura...
20/10/2025
Inside TAMS: How Time-Addressable Media Stores could redefine sports workflows By Paul Markham
Friday, October 17, 2025 - 08:57
Print This Story
A penalty...
20/10/2025
Transformational production: Inside TVN's remote production push for the DFL...
20/10/2025
How NBC Sports Transitioned Stamford Facility to One Format: 1080p HDRMulti-year plan harmonizes workflows, simplifies operationsBy Ken Kerschbaumer, Editorial ...
20/10/2025
NBA on NBC' Studio Production Team Is Ready for Tip-Off With Coast-to-Coast...
20/10/2025
Under pressure: TVN CEO Markus Osthaus considers the German sports broadcasting ...
20/10/2025
(L-R) Maria Dizzia, Carmen Emmi, and Russell Tovey attend the Plainclothes pre...
20/10/2025
In March, we launched Concerts Near You to help listeners find concerts from their favorite artists. Since then, more than 3 million people have used it to disc...
20/10/2025
Em diversas cidades do Brasil, um movimento tem se fortalecido para celebrar o poder, a beleza e a profundidade da criatividade negra. O Dia AMPLIFIKA, agora em...
20/10/2025
In cities across Brazil, a movement is growing that celebrates the power, beauty, and depth of Black creativity. AMPLIFIKA Day, now in its fifth edition, return...
20/10/2025
Airborne Early Warning and Control aircraft rendering...
20/10/2025
DENVER and MUNICH Imagine Communications today announced its plans to acquire Pixel Power Ltd., a wholly owned subsidiary of Rohde & Schwarz. Financial terms of...
20/10/2025
LOS ANGELES G Morgan has joined Globecast, a provider of broadcast, media and entertainment managed services, as executive vice president of sales, Globecast Am...
20/10/2025
PLYMOUTH, Wisc. Heartland Video Systems and Zixi have partnered to enable broadcast-quality live video delivery over any IP network....
20/10/2025
A. R. Rahman on Facing Fear and Finding the Divine In an interview with Berklee President Jim Lucchese, the Oscar-winning composer reflects on how courage and...
20/10/2025
Monday 20 October 2025
To view this content, please enable our use of cookies. ...
20/10/2025
Rohde & Schwarz transfers Pixel Power to Imagine Communications Companies work collaboratively to ensure continuity and ongoing support for existing customers...
20/10/2025
RT 's Prime Time is set to host the final Presidential Election Debate this Tuesday night, October 21, providing an opportunity to hear directly from Irelan...
20/10/2025
NVIDIA and Google Cloud are expanding access to accelerated computing to transform the full spectrum of enterprise workloads, from visual computing to agentic a...
19/10/2025
Back to All News
Sins of Kujo' Comes to Life in New Live-Action Series Set for Spring 2026
Entertainment
19 October 2025
GlobalJapan
Link copied to cl...
18/10/2025
New England Sports Network (NESN) has chosen Harmonic, working with Astound Business Solutions, as its enterprise technology partner to transform primary distri...
18/10/2025
NEW ORLEANS, La. In the run-up to the start of the NBA season, WVUE-TV and Gray Local Media have announced a deal with DirecTV that will greatly expand access t...
18/10/2025
Berklee Celebrates 40 Years of the Fall Together Concert Faculty composers Bob Pilkington and Greg Hopkins are among the featured artists for this year's ...
17/10/2025
NEP Group Receives New Equity Investment From 26North Partners LP, Co-InvestorsCarlyle remains the largest shareholder as the company prepares for the futureBy ...
17/10/2025
Apple Lands Five-Year Deal for F1 Distribution in the U.S.Besides airing on Apple TV, the sport will be amplified on other Apple servicesBy Ken Kerschbaumer, Ed...
17/10/2025
SVG Sit-Down: Marshall Electronics' Bernie Keach on the Future of PTZ Camera...
17/10/2025
L2 Productions' REMI Facility in Austin Can Produce Content From AnywhereMusic festivals, sports events are produced via flypacks and remote control roomsBy...
17/10/2025
By Lucy Spicer
One of the most exciting things about the Sundance Film Festival...
17/10/2025
(L-R) Christopher Meyer, Addison Timlin, Cooper Raiff, Lili Reinhart, Alyah Chan...
17/10/2025
M sica e arte se uniram em uma noite especial na semana passada na ZIV Gallery, ...
17/10/2025
Music and art came together for one special night last week at ZIV Gallery, an i...
17/10/2025
Spotify and FC Barcelona are extending our partnership through 2030, continuing a collaboration that's redefining how fans, players, and artists connect. Th...
17/10/2025
MURRIETA, Calif. The Sports Fishing Championship (SFC) has deployed DigitalGlue's creative.space storage platform to streamline video production by centrali...
17/10/2025
BELLEVUE, Wash. Football continued to cement its reputation as a bulwark of TV advertising in Q3 2025 with new data from iSpot that showed both the NFL and coll...
17/10/2025
The Sports Fishing Championship (SFC), the premier competitive saltwater fishing series, has transformed its production workflow by adopting creative.space, the...
17/10/2025
QuickLink, a leading provider of award-winning multi-camera video productions and remote contribution solutions, announces the release of StudioPro Version 4, ...
17/10/2025
Although the annual Grammy Awards celebration is best known for recognizing achievements in the recording industry, the show often proves a visual spectacle as ...
17/10/2025
OpenDrives, Inc., a leading provider of software-defined data storage and data services, has promoted Alex Dunfey to Chief Technology Officer (CTO) from his for...
17/10/2025
The University of Arizona (UofA) has significantly upgraded its broadcast communication infrastructure with the integration of Riedel Communications' advanc...
17/10/2025
Harmonic (NASDAQ: HLIT) today announced that New England Sports Network (NESN), owned by Fenway Sports Group and Delaware North, has selected Harmonic as its en...
17/10/2025
Austin PBS has recently upgraded its facility-wide communications infrastructure, deploying Clear-Com 's Eclipse HX, FreeSpeak II beltpacks, and V-Series ...
17/10/2025
ZEISS announces an open call for the closed BETA testing phase of CinCraft Virtual Lens Technology, the innovative digital tool that brings authentic lens chara...
17/10/2025
Situated in the town of Kokkola, Centria University of Applied Sciences offers higher education across five core fields: engineering, business, social and healt...
17/10/2025
Public information channel in Georgia, USA, to implement a powerful, simple, and cost-effective playout automation platform.
Pebble, the leading automation, co...
17/10/2025
HBO Max is reporting that it has launched in 15 new markets, including Bangladesh, Cambodia, Macau, Pakistan, Sri Lanka and Ukraine, boosting the streaming serv...
17/10/2025
Netflix said it will make a major push into video podcasts, inking a wide-ranging deal with Spotify through which it will offer 16 podcasts in the U.S. starting...
17/10/2025
Lexington, Ky. As part of a push to highlight its advanced advertising capabilities, Viamedia has launched a new AI-powered ad tech platform and officially rebr...
17/10/2025
NEW YORK QuickLink has announced the release of StudioPro Version 4, which the company is calling the most significant upgrade yet to its flagship video product...
17/10/2025
NEW YORK and CUPERTINO, Calif. Apple and NBCUniversal said they will sell Apple TV and Peacock streaming bundles to U.S. subscribers starting Oct. 20....
TSRI scientists zero in on treatment for Charcot-Marie-Tooth disease LA JOLLA, CA March 8, 2018 About 1 in 2,500 people have a degenerative nerve disease called Charcot-Marie-Tooth (CMT). The disease is typically diagnosed in children, who can lose their ability to walk and use their hands for fine motor skills. There is no cure yet.
